A Comparison of the Post-C/S Analgesic Effects of Neuraxial Duramorph vs

Status Terminated

Clinical Trial Summary

The primary objective is to reduce or eliminate the use of all narcotics/opiates for post Cesarean section pain management. The investigators hypothesize that in comparison with epidural or intrathecal Duramorph, a TAP block with liposomal bupivacaine (Exparel) will provide better, longer-acting pain control and will significantly reduce the use of post-operative IV or p.o. opiates. This is a prospective, randomized clinical trial.

Clinical Trial Description

The investigators will compare the analgesic efficacy and duration of an ultrasound guided bilateral TAP Block (with combined bupivacaine and liposomal bupivacaine) to Duramorph (an opiate). Neuraxial duramorph provides approximately 24 hours of pain relief (analgesia), whereas a bilateral TAP block with liposomal bupivacaine is expected to provide up to 72 hours of analgesia. All participants will have neuraxial anesthesia (either a spinal or epidural) for their non-urgent or elective Cesarean section. The control group (Group 1) will receive either intrathecal or epidural Duramorph (preservative-free morphine sulfate). Post-operatively, participants will have orders to receive, on an as-needed basis, IV/oral acetaminophen and/or IV/oral non-steroidal anti-inflammatory drugs (NSAIDS) for mild-moderate pain, and narcotics for severe pain; specifically- oxycodone or hydromorphone. All patients must receive acetaminophen and NSAIDS (unless contraindicated) before receiving narcotics. This multi-modal pain management regimen is our current standard of care. The experimental group (Group 2) will also receive a spinal or epidural anesthetic. This group will not receive neuraxial Duramorph for post-operative pain. Instead, the patient will receive an ultrasound guided bilateral TAP block with a combination of bupivacaine and liposomal bupivacaine solution immediately after the Cesarean section. Additionally, all participants will receive the same post-operative analgesia orders as group 1. ;

Study Design

Related Conditions & MeSH terms

Caesarean Section

Clinical Trial Details

NCT number	NCT03638011
Study type	Interventional
Source	Maimonides Medical Center
Contact
Status	Terminated
Phase	Phase 4
Start date	September 25, 2018
Completion date	June 30, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04238741` - Audio-recording of Consent for Anaesthesia for Elective Caesarean Section	N/A
Completed	`NCT01718236` - Modern Myorelaxation Procedure and Reversal of Neuromuscular Blockade With General Anesthesia for Caesarean Section	Phase 4
Completed	`NCT03199170` - Effect of Bilateral Quadratus Lumborum Block for Pain Relief in Patients With Cesarean Section	N/A
Completed	`NCT03309163` - Effect of Tramadol in Prevention of Postpartum Depression	Phase 4
Completed	`NCT03711552` - Validation of an Obstetric QoR Score and to Establish Its MCID.
Not yet recruiting	`NCT05583214` - Evaluating the Effectiveness of Ondansetron Versus Dexamethasone Versus Placebo for the Control of Intraoperative Nausea and Vomiting in Patients Undergoing Lower-segment Caesarean Section Under Spinal Anesthesia	Phase 4
Recruiting	`NCT06070844` - Yoga Nidra and Pain After Caesarean Section	N/A
Recruiting	`NCT06070792` - Neurolinguistic Programming, Progressive Muscle Relaxation Exercises, and Breastfeeding	N/A
Recruiting	`NCT06135961` - Intrapartum Non-invasive Electrophysiological Monitoring	N/A
Recruiting	`NCT04435496` - Study to Evaluate the Learning Curve to Anchor GYN-CS® Device	N/A
Completed	`NCT00916812` - Sensitivity of Hyomental Distance Ratio as a Single Predictor of Difficult Intubation in Obstetrics
Completed	`NCT05520580` - Effect of Mother's Push at Cesarean Delivery Mother's PUSHING AT CS A RANDOMIZED CONTROLLED TRIAL	N/A
Recruiting	`NCT02755168` - External Pop-Out Technique Versus Classic Head Extraction During Cesarean Section	N/A
Completed	`NCT02285569` - The Pleth Variability Index and Hypotension at Caesarean Under Spinal.	N/A
Completed	`NCT01210300` - Exploring Taiwanese Womens' Decision-making Regarding Vaginal Birth After Caesarean Section	N/A
Completed	`NCT03653442` - Non Invasive Haemodynamics in Neuraxial Anaesthesia Hypotension
Completed	`NCT03134677` - The Effects of Different Anesthetic Techniques on QT, Corrected QT (QTc), and P Wave Dispersions in Cesarean Section	Phase 4
Not yet recruiting	`NCT05446311` - Naldebain® Extended-release Injection After Cesarean Section in Pain Management
Completed	`NCT01278238` - Optimization of Hemodynamic Conditions During Caesarean Section Under Spinal Anaesthesia	N/A
Completed	`NCT04172727` - Subarachnoid Block With Ultrasound-Guided Transversalis Fascia Plane Block for Cesarean Section	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Comparison of the Post-C/S Analgesic Effects of Neuraxial Duramorph vs Bilateral TAP Block With Liposomal Bupivacaine

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms